Skip to content

Cefepime Antibiotic Level (Serum/Plasma)

Published: August 9, 2026Updated: August 15, 2026

This test measures the amount of the antibiotic cefepime in your blood. It helps doctors determine if your dose is working properly and whether you need adjustments.

Quick summary

["This test helps ensure your antibiotic is at the right level to fight infection safely."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 15, 2026Editorial policy

Key facts at a glance

LOINC
73045-7
Short code
CEFNEUTM
Synonyms
Cefepime (neut) IgM SerPl Ql FC
Category
chemistry
Sample
serum
Container
Serum separator tube (SST) or red-top clot tube; plasma collected in EDTA or heparin tube acceptable
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
flow-cytometry
CPT
86021
SNOMED
395146007
Specimen volume
2-5 mL of whole blood yielding 1-2 mL of serum or plasma
Stability
Refrigerated (2-8°C) for up to 7 days; frozen (-20°C or below) for up to 30 days; avoid repeated freeze-thaw cycles
Hemolysis max
100
Lipemia max
100
Icterus max
50
TAT
48–120 hours
Order
routine

Why This Test Is Done

Doctors may order this test if you’re taking cefepime, a broad-spectrum antibiotic used to treat serious bacterial infections like pneumonia, sepsis, or infections in the blood, bones, or joints. It helps monitor how well your body is responding to the medication and prevents potential side effects.

What to Expect Before the Test

No special preparation is needed. You’ll have a small needle inserted into your arm or vein to draw a blood sample. It usually takes a few minutes. If you’re on IV cefepime, your doctor may check levels during or shortly after treatment.

What the Results Mean

Results help doctors decide if your dose is too high (which could cause side effects) or too low (which might mean the infection isn’t fully treated). Exact values are interpreted by your healthcare provider based on your condition and treatment plan.

Common Side Effects & Risks

Cefepime is generally well-tolerated, but possible side effects include nausea, diarrhea, or allergic reactions. Rarely, it may cause kidney issues or nerve damage. Your doctor will watch for these and adjust your treatment as needed.

Reference range

Negative (antibody not detected)N/A

Specimen: serum

No special patient preparation required. Specimen should be collected prior to administration of next dose if clinically feasible.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance

Short name

Cefepime Level

Frequently asked questions

How often should I get this test?
Your doctor will determine the timing based on your treatment plan—often within 1–2 hours after starting IV cefepime or at specific intervals during oral therapy.
Can I drink water before the blood draw?
Yes, you can drink water unless your doctor specifies otherwise. Hydration helps with blood flow but doesn’t affect the test results.
Will this test affect my other medications?
Cefepime is generally safe when taken with other medications, but your doctor may monitor interactions if you’re on blood thinners, kidney medications, or other antibiotics.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 15, 2026. · Read our editorial policy